Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL19971603 | 0.97 | CA1 (0.42) | CA1CA2HTTLMNASMN1; SMN2 | |
| SCHEMBL11143490 | 0.75 | LMNA (0.34) | HTTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL11108737 | 0.74 | — | — | |
| SCHEMBL27100041 | 0.74 | SMN1; SMN2 (0.35) | CA1CA2HTTLMNASMN1; SMN2 | |
| SCHEMBL22883321 | 0.74 | KDM4E (0.36) | CA1CA2HTTALDH1A1TSHR | |
| SCHEMBL21462096 | 0.74 | CA1 (0.54) | CA1CA2LMNANPC1RAB9A | |
| SCHEMBL21423123 | 0.72 | LMNA (0.34) | CA1HTTLMNASMN1; SMN2NPC1 | |
| SCHEMBL22883621 | 0.72 | — | — | |
| SCHEMBL11872162 | 0.72 | — | — | |
| SCHEMBL7212342 | 0.72 | CA1 (0.43) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116651502-A | Sulfonated polysulfone-based ionic liquid catalytic material and preparation method thereof | 北京理工大学 | 2023-08-29 | — | — | CN | claimed |
| US-4266048-A | Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1981-05-05 | — | — | US | claimed |
| US-4169011-A | PHOSPHORYLATION OF ADENOSINE, SULFONATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1979-09-25 | — | — | US | claimed |
| CN-116651502-A | Sulfonated polysulfone-based ionic liquid catalytic material and preparation method thereof | 北京理工大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-116651502-A | Sulfonated polysulfone-based ionic liquid catalytic material and preparation method thereof | 北京理工大学 | 2023-08-29 | — | — | CN | disclosed |
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | RHODIA OPERATIONS (FR) | 2011-11-24 | — | — | US | disclosed |
| US-8017719-B2 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2011-09-13 | — | — | US | disclosed |
| US-20090312502-A1 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2009-12-17 | — | — | US | disclosed |
| US-6605730-B2 | 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula | NIHON BAYER AGROCHEM K.K. (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20030028034-A1 | Nematicidal pyrazoles | WADA KATSUAKI (JP) | 2003-02-06 | — | — | US | disclosed |
| US-6440691-B1 | AIDS VIRICIDES | LARGE SCALE BIOLOGY CORPORATION | 2002-08-27 | — | — | US | disclosed |
| US-RE32261-E | Process for producing thermosetting finishing powders | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1986-10-07 | — | — | US | disclosed |
| US-4387221-A | Alkyl- and alkenyl-sulfosuccinate starchhalf-esters, a method for the preparation thereof | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1983-06-07 | — | — | US | disclosed |
| US-4266048-A | Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1981-05-05 | — | — | US | disclosed |
| US-4266048-A | Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1981-05-05 | — | — | US | disclosed |
| US-4242505-A | S-Adenosyl-L-methionine compositions and production thereof | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1980-12-30 | — | — | US | disclosed |
| US-4169011-A | PHOSPHORYLATION OF ADENOSINE, SULFONATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1979-09-25 | — | — | US | disclosed |
| US-4169011-A | PHOSPHORYLATION OF ADENOSINE, SULFONATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1979-09-25 | — | — | US | disclosed |
| US-4042645-A | ACRYLIC ESTER COPOLYMERS | MITSUI TOATSU CHEMICALS, INCORPORATED (JA) | 1977-08-16 | — | — | US | disclosed |
| US-3954898-A | Powder coating of epoxy resin, acrylic copolymer and tertiary amine | MITSUI TOATSU CHEMICALS, INCORPORATED (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | UROD, HPD, ALKBH3 | CA1 18/4885CA2 89/4885HTT 781/4885 |
| US-20030028034-A1 | Nematicidal pyrazoles | CBR3, CBR1, CCR4 | CA1 1995/4885CA2 322/4885HTT 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.